CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	58.49B
Revenue (ttm)	1.98B
Net Income (ttm)	53.73M
Shares Out	1.39B
EPS (ttm)	0.04
PE Ratio	1,088.65
Forward PE	66.70
Dividend	0.02 (0.05%)
Ex-Dividend Date	Apr 25, 2024

Volume	4,239,816
Average Volume	9,653,909
Open	42.90
Previous Close	41.21
Day's Range	40.62 - 42.90
52-Week Range	21.07 - 43.50
Beta	0.18
RSI	61.87
Earnings Date	Mar 21, 2025

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, Ch...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.